Logo image of EPAM

EPAM SYSTEMS INC (EPAM) Stock Fundamental Analysis

USA - NYSE:EPAM - US29414B1044 - Common Stock

144.52 USD
+2.32 (+1.63%)
Last: 10/17/2025, 8:08:23 PM
144.52 USD
0 (0%)
After Hours: 10/17/2025, 8:08:23 PM
Fundamental Rating

6

Overall EPAM gets a fundamental rating of 6 out of 10. We evaluated EPAM against 86 industry peers in the IT Services industry. EPAM has an excellent financial health rating, but there are some minor concerns on its profitability. EPAM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year EPAM was profitable.
In the past year EPAM had a positive cash flow from operations.
EPAM had positive earnings in each of the past 5 years.
Each year in the past 5 years EPAM had a positive operating cash flow.
EPAM Yearly Net Income VS EBIT VS OCF VS FCFEPAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

The Return On Assets of EPAM (8.52%) is better than 80.23% of its industry peers.
EPAM has a better Return On Equity (10.94%) than 67.44% of its industry peers.
EPAM has a better Return On Invested Capital (10.85%) than 75.58% of its industry peers.
EPAM had an Average Return On Invested Capital over the past 3 years of 11.98%. This is significantly below the industry average of 21.42%.
Industry RankSector Rank
ROA 8.52%
ROE 10.94%
ROIC 10.85%
ROA(3y)9.87%
ROA(5y)11.06%
ROE(3y)12.84%
ROE(5y)14.88%
ROIC(3y)11.98%
ROIC(5y)12.84%
EPAM Yearly ROA, ROE, ROICEPAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of EPAM (7.91%) is better than 74.42% of its industry peers.
EPAM's Profit Margin has declined in the last couple of years.
EPAM has a better Operating Margin (10.91%) than 72.09% of its industry peers.
EPAM's Operating Margin has declined in the last couple of years.
EPAM has a Gross Margin of 30.05%. This is in the lower half of the industry: EPAM underperforms 61.63% of its industry peers.
EPAM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.91%
PM (TTM) 7.91%
GM 30.05%
OM growth 3Y-7.24%
OM growth 5Y-2.7%
PM growth 3Y-9.14%
PM growth 5Y-3.32%
GM growth 3Y-3.28%
GM growth 5Y-2.67%
EPAM Yearly Profit, Operating, Gross MarginsEPAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

9

2. Health

2.1 Basic Checks

EPAM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for EPAM has been reduced compared to 1 year ago.
The number of shares outstanding for EPAM has been increased compared to 5 years ago.
EPAM has a better debt/assets ratio than last year.
EPAM Yearly Shares OutstandingEPAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EPAM Yearly Total Debt VS Total AssetsEPAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 7.21 indicates that EPAM is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.21, EPAM belongs to the top of the industry, outperforming 86.05% of the companies in the same industry.
EPAM has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.06, EPAM belongs to the top of the industry, outperforming 93.02% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that EPAM is not too dependend on debt financing.
EPAM has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. EPAM outperforms 81.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.06
Altman-Z 7.21
ROIC/WACC1.25
WACC8.67%
EPAM Yearly LT Debt VS Equity VS FCFEPAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 3.17 indicates that EPAM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.17, EPAM belongs to the top of the industry, outperforming 80.23% of the companies in the same industry.
EPAM has a Quick Ratio of 3.17. This indicates that EPAM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.17, EPAM belongs to the top of the industry, outperforming 81.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.17
Quick Ratio 3.17
EPAM Yearly Current Assets VS Current LiabilitesEPAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.22% over the past year.
Measured over the past years, EPAM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.89% on average per year.
Looking at the last year, EPAM shows a quite strong growth in Revenue. The Revenue has grown by 9.73% in the last year.
EPAM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.56% yearly.
EPS 1Y (TTM)7.22%
EPS 3Y6.34%
EPS 5Y14.89%
EPS Q2Q%13.06%
Revenue 1Y (TTM)9.73%
Revenue growth 3Y7.95%
Revenue growth 5Y15.56%
Sales Q2Q%18.04%

3.2 Future

Based on estimates for the next years, EPAM will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.94% on average per year.
EPAM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.84% yearly.
EPS Next Y3.9%
EPS Next 2Y7.04%
EPS Next 3Y8.45%
EPS Next 5Y8.94%
Revenue Next Year15.27%
Revenue Next 2Y11.11%
Revenue Next 3Y10.45%
Revenue Next 5Y9.84%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EPAM Yearly Revenue VS EstimatesEPAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EPAM Yearly EPS VS EstimatesEPAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.97 indicates a correct valuation of EPAM.
Based on the Price/Earnings ratio, EPAM is valued cheaper than 80.23% of the companies in the same industry.
EPAM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.40.
EPAM is valuated reasonably with a Price/Forward Earnings ratio of 11.60.
Based on the Price/Forward Earnings ratio, EPAM is valued cheaper than 80.23% of the companies in the same industry.
EPAM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.97
Fwd PE 11.6
EPAM Price Earnings VS Forward Price EarningsEPAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EPAM is valued a bit cheaper than 70.93% of the companies in the same industry.
EPAM's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EPAM is cheaper than 66.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.65
EV/EBITDA 10.62
EPAM Per share dataEPAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EPAM does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.32
PEG (5Y)0.87
EPS Next 2Y7.04%
EPS Next 3Y8.45%

0

5. Dividend

5.1 Amount

No dividends for EPAM!.
Industry RankSector Rank
Dividend Yield N/A

EPAM SYSTEMS INC

NYSE:EPAM (10/17/2025, 8:08:23 PM)

After market: 144.52 0 (0%)

144.52

+2.32 (+1.63%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners96.48%
Inst Owner Change-1.16%
Ins Owners3.6%
Ins Owner Change0.11%
Market Cap8.05B
Analysts80.87
Price Target218.1 (50.91%)
Short Float %3.48%
Short Ratio2.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.02%
Min EPS beat(2)3.97%
Max EPS beat(2)4.07%
EPS beat(4)4
Avg EPS beat(4)5.61%
Min EPS beat(4)1.07%
Max EPS beat(4)13.33%
EPS beat(8)8
Avg EPS beat(8)5.66%
EPS beat(12)12
Avg EPS beat(12)7.23%
EPS beat(16)16
Avg EPS beat(16)10.93%
Revenue beat(2)0
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)-0.48%
Revenue beat(4)1
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)0.84%
Revenue beat(8)1
Avg Revenue beat(8)-0.68%
Revenue beat(12)2
Avg Revenue beat(12)-0.74%
Revenue beat(16)5
Avg Revenue beat(16)0.24%
PT rev (1m)0.46%
PT rev (3m)-1.39%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)4.15%
EPS NY rev (1m)0.02%
EPS NY rev (3m)2.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.82%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)1.01%
Valuation
Industry RankSector Rank
PE 12.97
Fwd PE 11.6
P/S 1.59
P/FCF 19.65
P/OCF 17.91
P/B 2.19
P/tB 3.98
EV/EBITDA 10.62
EPS(TTM)11.14
EY7.71%
EPS(NY)12.45
Fwd EY8.62%
FCF(TTM)7.36
FCFY5.09%
OCF(TTM)8.07
OCFY5.59%
SpS91.04
BVpS65.85
TBVpS36.31
PEG (NY)3.32
PEG (5Y)0.87
Profitability
Industry RankSector Rank
ROA 8.52%
ROE 10.94%
ROCE 13.96%
ROIC 10.85%
ROICexc 14.72%
ROICexgc 33.69%
OM 10.91%
PM (TTM) 7.91%
GM 30.05%
FCFM 8.08%
ROA(3y)9.87%
ROA(5y)11.06%
ROE(3y)12.84%
ROE(5y)14.88%
ROIC(3y)11.98%
ROIC(5y)12.84%
ROICexc(3y)23.91%
ROICexc(5y)27.45%
ROICexgc(3y)44.54%
ROICexgc(5y)48.5%
ROCE(3y)15.42%
ROCE(5y)16.54%
ROICexcg growth 3Y-11.88%
ROICexcg growth 5Y3.29%
ROICexc growth 3Y-20.35%
ROICexc growth 5Y-8.92%
OM growth 3Y-7.24%
OM growth 5Y-2.7%
PM growth 3Y-9.14%
PM growth 5Y-3.32%
GM growth 3Y-3.28%
GM growth 5Y-2.67%
F-Score6
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.06
Debt/EBITDA 0.04
Cap/Depr 36.56%
Cap/Sales 0.79%
Interest Coverage 250
Cash Conversion 67.9%
Profit Quality 102.14%
Current Ratio 3.17
Quick Ratio 3.17
Altman-Z 7.21
F-Score6
WACC8.67%
ROIC/WACC1.25
Cap/Depr(3y)51.75%
Cap/Depr(5y)79.67%
Cap/Sales(3y)0.99%
Cap/Sales(5y)1.71%
Profit Quality(3y)111.75%
Profit Quality(5y)115.25%
High Growth Momentum
Growth
EPS 1Y (TTM)7.22%
EPS 3Y6.34%
EPS 5Y14.89%
EPS Q2Q%13.06%
EPS Next Y3.9%
EPS Next 2Y7.04%
EPS Next 3Y8.45%
EPS Next 5Y8.94%
Revenue 1Y (TTM)9.73%
Revenue growth 3Y7.95%
Revenue growth 5Y15.56%
Sales Q2Q%18.04%
Revenue Next Year15.27%
Revenue Next 2Y11.11%
Revenue Next 3Y10.45%
Revenue Next 5Y9.84%
EBIT growth 1Y11.21%
EBIT growth 3Y0.14%
EBIT growth 5Y12.45%
EBIT Next Year16.3%
EBIT Next 3Y12.45%
EBIT Next 5Y11.07%
FCF growth 1Y-26.81%
FCF growth 3Y4.58%
FCF growth 5Y22.87%
OCF growth 1Y-26.87%
OCF growth 3Y-0.77%
OCF growth 5Y14.23%